Haemonetics HAE Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's accumulated depreciation?
- Haemonetics (HAE) reported accumulated depreciation of $539.58M in Q4 2025.
- How has Haemonetics's accumulated depreciation changed year-over-year?
- Haemonetics's accumulated depreciation decreased by 7.2% year-over-year, from $581.35M to $539.58M.
- What is the long-term trend for Haemonetics's accumulated depreciation?
- Over 4 years (2021 to 2025), Haemonetics's accumulated depreciation has grown at a 14.6% compound annual growth rate (CAGR), from $320.64M to $553.14M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.